In a statement to PEOPLE, an Eli Lilly spokesperson said, "FDA’s decision reiterating that the tirzepatide shortage is resolved reflects the tireless work of our manufacturing and quality ...
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...
Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly ...
Amid new worries that legal copycats of the weight-loss drugs from Eli ... pen pay out of pocket depends on their insurance. For patients whose commercial coverage doesn’t cover Zepbound, Lilly ...